| |
|
Form Serial Number: |
DA20250203E00516
|
| 1.
Date of relevant event: |
24/01/2025
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02453 |
| 4.
Name of listed corporation: |
Concord Healthcare Group Co., Ltd. - H Shares |
| 5.
Class of shares: |
Domestic Shares |
| 6.
Number of issued shares in class: |
469,787,392 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
YANG |
| (Other names) |
Jianyu |
|
|
|
| 10.
Name of director (Chinese): |
杨建宇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1305 | There has been a change in nature of your interest in the shares because:
you have provided an interest in the shares as security to a person other than a qualified lender |
|
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
8,967,318 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 205,607,968 | 43.77 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 205,607,968 | 43.77 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Morgancreek Investment Holdings Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | YANG Jianyu | 100.00 | N | |
| Concord Medical Services Holdings Limited | Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands; Cayman Islands | Morgancreek Investment Holdings Limited | 73.20 | N | |
| Ascendium Group Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | Concord Medical Services Holdings Limited | 100.00 | N | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | Y | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | N | |
| Shanghai Xinhe Enterprise Management Center (Limited) Partnership | Room 2085, Area B, 2nd Floor, Building 2, No. 715 Yingshun Road, Qingpu District, Shanghai, PRC; People's Republic of China | Medstar (Shanghai) Enterprise Management Co., LTD | 72.73 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
On July 10, 2024, October 14, 2024 and January 24, 2025, Medstar (Shanghai) Enterprise Management Co., LTD pledged 23,070,000 Domestic Shares, 64,100,000 Domestic Shares and 8,967,318 Domestic Shares in favor of China Credit Trust Co., Ltd. as security for a loan facility, respectively. Please refer to the announcements of the listed corporateion dated July 10, 2024, October 14, 2024 and January 24, 2025.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
03/02/2025
(dd/mm/yyyy)
|
| |
